Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HRO761 |
Trade Name | |
Synonyms | HRO-761|HRO 761 |
Drug Descriptions |
HRO761 inhibits WRN, locking it in an inactive conformation, which leads to activation of the DNA damage response and potentially inhibiting tumor growth (PMID: 38658754). |
DrugClasses | |
CAS Registry Number | 2869954-34-5 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HRO761 | HRO761 | 0 | 1 |
HRO761 + Irinotecan | HRO761 Irinotecan | 0 | 1 |
HRO761 + Tislelizumab | HRO761 Tislelizumab | 0 | 1 |